12/02/2024 6:10 PM | Fulgent Genetics (Subject) Xie Jian (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
12/02/2024 6:10 PM | Fulgent Genetics (Subject) Gao Hanlin (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
11/25/2024 6:03 PM | Fulgent Genetics (Subject) Hsieh Ming (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
11/25/2024 6:03 PM | Fulgent Genetics (Subject) Gao Hanlin (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
11/25/2024 6:04 PM | Fulgent Genetics (Subject) Xie Jian (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
11/08/2024 6:17 AM | Fulgent Genetics (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
11/08/2024 6:10 AM | Fulgent Genetics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
|
11/01/2024 3:30 PM | Fulgent Genetics (Issuer) Gao Hanlin (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/29/2024 3:30 PM | Fulgent Genetics (Issuer) Xie Jian (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/29/2024 3:30 PM | Fulgent Genetics (Issuer) Kim Paul (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/29/2024 3:30 PM | Fulgent Genetics (Issuer) Gao Hanlin (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/05/2024 3:20 PM | Fulgent Genetics (Issuer) Gao Hanlin (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/05/2024 3:21 PM | Fulgent Genetics (Issuer) Xie Jian (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/05/2024 3:21 PM | Fulgent Genetics (Issuer) Kim Paul (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/03/2024 6:36 PM | Fulgent Genetics (Subject) Kim Paul (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
09/03/2024 6:37 PM | Fulgent Genetics (Subject) Xie Jian (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
08/29/2024 5:33 PM | Fulgent Genetics (Issuer) Kim Paul (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/29/2024 5:33 PM | Fulgent Genetics (Issuer) Hsieh Ming (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/29/2024 5:33 PM | Fulgent Genetics (Issuer) Xie Jian (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/29/2024 5:34 PM | Fulgent Genetics (Issuer) Gao Hanlin (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/27/2024 7:22 PM | Fulgent Genetics (Subject) Hsieh Ming (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
08/02/2024 6:38 AM | Fulgent Genetics (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
08/02/2024 6:09 AM | Fulgent Genetics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
07/30/2024 3:27 PM | Fulgent Genetics (Issuer) Gao Hanlin (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/30/2024 3:28 PM | Fulgent Genetics (Issuer) Kim Paul (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/30/2024 3:29 PM | Fulgent Genetics (Issuer) Xie Jian (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/28/2024 3:22 PM | Fulgent Genetics (Issuer) Gao Hanlin (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/28/2024 3:22 PM | Fulgent Genetics (Issuer) Xie Jian (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/20/2024 5:04 PM | Fulgent Genetics (Issuer) Marsh Linda (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/20/2024 5:05 PM | Fulgent Genetics (Issuer) GROVES REGINA E (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/20/2024 5:06 PM | Fulgent Genetics (Issuer) Nohaile Michael (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/16/2024 3:29 PM | Fulgent Genetics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/07/2024 3:21 PM | Fulgent Genetics (Issuer) Kim Paul (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/07/2024 3:22 PM | Fulgent Genetics (Issuer) Xie Jian (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/03/2024 6:34 AM | Fulgent Genetics (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
05/03/2024 6:05 AM | Fulgent Genetics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/02/2024 3:35 PM | Fulgent Genetics (Issuer) Gao Hanlin (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/12/2024 6:07 PM | Fulgent Genetics (Issuer) Hsieh Ming (Reporting) Ming Hsieh Trust (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/05/2024 3:26 PM | Fulgent Genetics (Issuer) Gao Hanlin (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/05/2024 3:27 PM | Fulgent Genetics (Issuer) Kim Paul (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/05/2024 3:28 PM | Fulgent Genetics (Issuer) Xie Jian (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
AI breakthrough about to upend industry (Ad) Everyone is talking about AI right now.
The talk has been endless ever since ChatGPT was released to the market in late 2022. You might think it’s way too late to invest in AI.
But here’s the thing. I urge you to watch it now. |
02/28/2024 6:10 PM | Fulgent Genetics (Issuer) Xie Jian (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/28/2024 6:11 PM | Fulgent Genetics (Issuer) Hsieh Ming (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/28/2024 6:11 PM | Fulgent Genetics (Issuer) Kim Paul (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/28/2024 6:12 PM | Fulgent Genetics (Issuer) Gao Hanlin (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/28/2024 6:08 AM | Fulgent Genetics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/27/2024 5:50 PM | Fulgent Genetics (Issuer) Gao Hanlin (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/27/2024 5:52 PM | Fulgent Genetics (Issuer) Xie Jian (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/27/2024 5:55 PM | Fulgent Genetics (Issuer) Kim Paul (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/27/2024 5:48 PM | Fulgent Genetics (Issuer) Hsieh Ming (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/06/2024 6:27 PM | Fulgent Genetics (Issuer) Kim Paul (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/06/2024 6:26 PM | Fulgent Genetics (Issuer) Xie Jian (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/05/2024 3:01 PM | Fulgent Genetics (Issuer) Hsieh Ming (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/01/2024 3:39 PM | Fulgent Genetics (Issuer) Gao Hanlin (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/30/2024 3:21 PM | Fulgent Genetics (Issuer) Xie Jian (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/30/2024 3:21 PM | Fulgent Genetics (Issuer) Gao Hanlin (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/30/2024 3:21 PM | Fulgent Genetics (Issuer) Kim Paul (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |